Wouldn't be surprised if potential bidders have approached the company already (they did hire the advisor), but I'm guessing they have been sent right back out the door to reflect on how petty their offers were. Management know what this is worth, and I'm hoping as money flows back into bio/healthcare stocks the bidders will be a bit more realistic with their offers
ANAVEX MEETS ENDPOINTS PHASE2 RETT, page-115
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.39 |
Change
-0.470(2.37%) |
Mkt cap ! $2.478B | |||
| Open | High | Low | Value | Volume |
| $19.70 | $19.77 | $19.28 | $10.38M | 534.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2680 | $19.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.41 | 362 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |